AirNexis Therapeutics, Inc.

AirNexis Therapeutics, Inc.

Biotechnology · Palo Alto · United States

0 followers

AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
https://airnexis.com ↗

Reviews from employees

No reviews yet.

Open jobs at AirNexis Therapeutics, Inc.

No open jobs at the moment.

Contact us about this company

Explore the Broxer community

🤖
Online · instant AI help
Broxer